Literature DB >> 30919140

Different Clonal T-Large Granular Lymphocyte Proliferations in SCID.

Süreyya Savaşan1,2,3, Erin Wakeling4, Tristan Knight5, Steven Buck5,6, Manisha Gadgeel5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30919140     DOI： 10.1007/s10875-019-00614-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  5 in total

1.  Large granular lymphocyte expansion after allogeneic hematopoietic stem cell transplant is associated with a cytomegalovirus reactivation and shows an indolent outcome.

Authors:  Sabine Nann-Rütti; Alexander Tzankov; Nathan Cantoni; Jörg Halter; Dominik Heim; Dimitrios Tsakiris; Caroline Arber; Andreas Buser; Alois Gratwohl; André Tichelli; Alicia Rovó
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-14       Impact factor: 5.742

Review 2.  LGL leukemia: from pathogenesis to treatment.

Authors:  Thierry Lamy; Aline Moignet; Thomas P Loughran
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

3.  Co-existence of clonal expanded autologous and transplacental-acquired maternal T cells in recombination activating gene-deficient severe combined immunodeficiency.

Authors:  A Lev; A J Simon; J Ben-Ari; D Takagi; T Stauber; L Trakhtenbrot; E Rosenthal; G Rechavi; N Amariglio; R Somech
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

4.  Three cases of primary EBV infection in young adults manifested by periorbital and eyelid oedema.

Authors:  Elisa Demonchy; Céline Pulcini
Journal:  Infection       Date:  2013-06-20       Impact factor: 7.455

5.  Somatic STAT3 mutations in Felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia.

Authors:  Paula Savola; Oscar Brück; Thomas Olson; Tiina Kelkka; Markku J Kauppi; Panu E Kovanen; Soili Kytölä; Tuulikki Sokka-Isler; Thomas P Loughran; Marjatta Leirisalo-Repo; Satu Mustjoki
Journal:  Haematologica       Date:  2017-12-07       Impact factor: 9.941
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.